mak et al-2012-alimentary pharmacology & therapeutics

Upload: muhammad-erlangga-sudina

Post on 07-Aug-2018

212 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics

    1/11

  • 8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics

    2/11

    INTRODUCTION

    Dyspepsia is a common gastrointestinal condition that is

    characterised by chronic recurrent epigastric symptoms

    such as pain, burning and postprandial symptoms. Dys-

    pepsia is associated with signicant functional impair-

    ment and burden on healthcare resources.1 Estimates of 

    community prevalence of dyspepsia have varied widely 

    from 5% to 40%2 depending on criteria used. Yet,

    community prevalence measured using strictly applied

    Rome III criteria,3 which are more precise and restrictive

    than their predecessors, remains sparse.4

    It has been reported that comorbid psychiatric disor-

    ders are common in patients with dyspepsia. Generalised

    anxiety disorder (GAD) and Major depressive episodes

    (MDE), in particular, have been most extensively related

    to dyspepsia. These three disorders share several

    commonalities. Similar to functional dyspepsia, both

    GAD and MDE are typically chronic and relapsing, more

    common in female, with onset and exacerbation oftenassociated with psychosocial stress.5, 6 Moreover, visceral

    hypersensitivity and somatisation have been associated

    with all three conditions.4, 7 – 10

    Studies have found increased anxiety and depressive

    symptoms   on rating scales,11 and poorer psychological

    wellbeing 12 in organic and functional dyspepsia. How-

    ever, their relevance to how specic comorbid mental

    disorders   may contribute to the clinical and societal

    burden of dyspeptic symptoms12 remains unclear. As

    effective interventions exist for mental disorders,

    their treatment may benet the clinical outcome of dyspepsia.13

    To date, most studies on psychiatric correlates in dys-

    peptic patients came from referral centres and clinics.4

    Selection bias may distort any association of psychiatric

    morbidity and dyspepsia found in these samples, because

    only 25 – 42%14 of dyspepsia sufferers in the community 

    seek medical care. It is unclear whether psychological

    distress may motivate or hinder patients in seeking care

    for dyspeptic symptoms. The recent community-based

    Kalixanda study 15 evaluated the relationship between

    anxiety, depression and functional dyspepsia. It foundanxiety, but not depression, to be associated with func-

    tional and organic dyspepsia. However, the Rome III

    criteria used in this study were   post hoc   rated from a

    Rome II questionnaire with the Rome III 6-month onset

    criterion discarded. Meanwhile, HADS, as with most

    psychiatric symptom scales, captured symptoms as a

    dimensional score, and did not meet the duration

    and impairment requirements for diagnosis of GAD

    and MDE as   mental disorders   dened by the American

    Psychiatric Associations’   Diagnostic and Statistical

    Manual of Mental Disorders, Fourth Edition- Text

    Revision (DSM-IV-TR)16 (Tables 2 and 3). Using the

    Structured Clinical Interview for DSM-IV Axis-I

    Disorder (SCID-I),17 we found 38.2% and 16.4% of 

    Chinese patients in a tertiary gastroenterology clinic with

    functional dyspepsia to have an anxiety disorder and

    depressive disorder respectively.18

    We therefore set out to conduct a community survey 

    to examine the current community prevalence of strin-

    gently dened Rome III Dyspepsia (Table 1), as well as

    the 12-month prevalence of GAD and MDE using 

    DSM-IV-TR. We also evaluated the association between

    dyspepsia, GAD and MDE and the chronological

    relationship of their onsets. Although rarely examined

    in previous studies, the latter may shed light on

    whether these illnesses may be causally related to each

    other.19

    METHODS

    A random community-based telephone survey of the

    general population in the age range of 15 – 65 years was

    conducted from 22nd April to 13th May, 2009. The

    study was approved by the research ethics committee of 

    The Chinese University of Hong Kong. The Hong Kong 

    Institute of Asia-Pacic Studies of the Chinese University 

    of Hong Kong, an independent survey research organisa-

    tion, was commissioned to conduct the survey. Inter-

     viewers were university students with 1 – 3 years of 

    part-time experience in telephone interviews. A brieng session was held by the investigators (AM, JW, YC) for

    training of administration of the questionnaire and

    explaining skills involved in eliciting symptoms of dys-

    pepsia, GAD and MDE. Respondents were invited to

    take part in a telephone survey of   ‘digestive problems

    and emotional health’. Interviews proceeded only after

     verbal consent was sought. The interviews were

    conducted in Cantonese dialect, the predominant spoken

    Table 1 |   Rome III symptomatic criteria for functionaldyspepsia

    3

    Must include

    One or more  of

    a Bothersome postprandial fullness

    b Early satiation

    c Epigastric pain

    d Epigastric burning

    Criteria fullled for the last 3 months with symptom onset at

    least 6 months before diagnosis.

    Aliment Pharmacol Ther 2012; 36: 800-810   801ª  2012 Blackwell Publishing Ltd

    Community study on dyspepsia, depression and anxiety

  • 8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics

    3/11

  • 8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics

    4/11

    MDE (Tables 2 and 3) based on DSM-IV-TR Criteria

    and healthcare utilisation.

    The same questionnaire for GAD and MDE diagnoses

    had been used in previous series of telephone surveys

    that found 12-month prevalence of GAD to be 4.1%22

    and 8.4% for major depressive episode (MDE).23 Clinical

    re-appraisal for diagnoses of MDE and GAD using the

    gold standard of psychiatric diagnosis in research, the

    Table 3 |   Survey questions pertaining to the DSM IV-TR symptoms of major depressive episode

    DSM  – IV criteria Questions in the telephone survey

    Required response for

    diagnosis

    FIVE or more of the following in the same

    2 week period, representing a change from

    previous functioning. At least ONE should

    be either (1) or (2)1. Depressed mood most of the day, nearly

    every day (reported or observed)

    2. Markedly diminished interest or pleasure

    in (almost) all activities most of the day,

    nearly every day (reported or observed)

    3. Signicant weight loss

    4. Insomnia or hypersomnia nearly every

    day

    5. Psychomotor agitation or retardation

    nearly every day (observed + subjective)

    6. Fatigue or loss of energy nearly every day

    7. Feelings of worthlessness or excessive or

    inappropriate guilt nearly every day (not

    merely self-reproach or guilt about beingsick)

    8. Diminished ability to think or

    concentrate, or indecisiveness, nearly

    every day (subjective or objective)

    9. Recurrent thoughts of death (not just fear

    of dying), recurrent suicidal ideation

    without a specic plan, or a suicide

    attempt or a specic plan for committing

    suicide.

    A1. In the past year, have you had 2 weeks

    or longer when you had depressed mood

    most of the day, nearly every day?

    A2. In the past year, have you had 2 weeksor longer when you had markedly reduced

    interest or pleasure in almost all activities

    most of the time, nearly every day?

    ‘Yes’   in A1 or A2

    B. During the period when you had

    (depressed mood) (reduced interest or

    pleasure), did you often have

    a Poor appetite or lost weight

    b Slept less than usual

    c Observable slowing of speech or actions

    d Fatigue or loss of energy

    e Difculty to concentrate or make

    decisions

    f Observable restlessness and agitation

    g Increased appetite or body weight

    h Slept more than usual

    i Felt worthless

     j Thoughts of death or suicide

    a and g counted as 1

    item

    b and h counted as 1

    item

    c and f counted as 1

    item

    ‘Yes’   in at least FIVE

    items in sections A and

    B, including at least one

    item in A.

    D. Clinically signicant distress or

    impairment in social, occupational/other

    important areas of functioning

    D1. Did the above experiences cause you

    signicant distress? AND/OR

    ‘Very distressed’ or

    ‘Quite distressed’ AND/

    OR

    D. Clinically signicant distress orimpairment in social, occupational/other

    important areas of functioning

    D2. Did the above experiences signicantlyimpair your daily life (e.g. study/work,

    social & family life?

    ‘Very impaired’  or   ‘Quiteimpaired’

    Aliment Pharmacol Ther 2012; 36: 800-810   803ª  2012 Blackwell Publishing Ltd

    Community study on dyspepsia, depression and anxiety

  • 8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics

    5/11

    Structured Clinical Interview for DSM-IV Axis-I Disor-

    ders (SCID-I) yielded good agreement.24, 25 The same

    series of telephone survey had assessed prevalence of Rome III Irritable Bowel Syndrome in Hong Kong to be

    5.4%, comparable while conservative, with overseas esti-

    mates.26

    We also asked   ‘how much did you spend over the past

    5 years on investigations for your gastrointestinal

    problems?’   to assess investigation expenditure and   ‘how 

    frequently did you see a doctor for your health problems’

    to assess frequency of consultations. Subjects were also

    asked for each disorder their respective ages when the

    disorder   rst came on in their lives so as to estimate

    chronological association of the disorders.

    Study power

    Power calculation was performed   post hoc   based on the

    sample collected to estimate the size of odds ratio that

    can be detected in the whole sample and the dyspepsia

    subgroup. With an overall sample (n   =   2011), a logistic

    regression of binary response variable of dyspepsia

    (n   =  142, 7% dyspepsia without MDE) on the binary 

    independent variable of GAD (n   =  77, 3.8%), to

    achieve 80% power at a signicance level of 0.05, will

    have a minimum detectable odds ratio of 2.60. For

    the dyspepsia-only subgroup (n   =  161), for logistic

    regression of binary response variable of GAD (n   =  4,

    4% GAD without MDE) on the binary independent vari-

    able of MDE (n   =  53, 33%), the minimum detectable

    odds ratio would be 5.24, to achieve 80% power at a sig-

    nicance level of 0.05.27

    Analysis

    The current prevalence of dyspepsia and 12-month prev-

    alence of generalised anxiety disorder and major depres-

    sive episode were presented as percentages. The study 

    sample was weighted (Appendix S1) according to age and

    sex distribution of the Hong Kong general population

    based on the 2008 Census data (Table 4). To identify 

    Phone calls made withvalid telephone numbers

    (n  = 6378)

    No suitable respondent(n  = 720)

    n  = 3793

    Interview refused by otherfamily members (n = 931)

    n  = 2862

    n  = 2142

    Hung up immediately(n  = 2585)

    n  = 2093

    Failure to contactsuitable respondent (n  = 49)

    Successfully interviewedrespondents n  = 2011

    Refused by suitablerespondent (n  = 82)

    Figure 1 |   Flow diagram depicting various reasons for

    and number of subjects who did not participate in the

    study.

    Table 4 |   Sociodemographic characteristics of the

    respondents and comparison with Hong Kong Census

    data

    Total sample

    (n   =   2011), % (n)

    % Census

    2008*

    Gender

    Male 46.6 (937) 47.2

    Female 53.4 (1074) 52.8

    Age

    15 – 24 16.9 (341) 17.0

    25 – 34 20.4 (411) 20.4

    35 – 

    44 22.5 (454) 22.645 – 54 24.3 (488) 24.2

    55 – 65 15.8 (317) 15.8

    Education

    Primary or below 11.3 (317)   – 

    Secondary 45.2 (905)   – 

    Pre college 10.3 (206)   – 

    College or above 33.3 (667)   – 

    Work status

    Employed 60.6 (1212)   – 

    Unemployed 6.4 (129)   – 

    Retired 7.0 (141)   – 

    Student 12.1 (241)   – 

    Homemaker 13.8 (278)   – 

    Marital statusSingle 38.4 (769)   – 

    Married/living together 59.4 (1190)   – 

    Previously married 2.1 (43)   – 

    Income level

    HKD     10 000 20.8 (389)   – 

    HKD 10 000 – 30 000 46.6 (869)   – 

    HKD 30 000 – 60 000 22.3 (416)   – 

    HKD 60 000 10.3 (192)   – 

    * Data from Hong Kong Census and Statistics Department,

    2008.

    804   Aliment Pharmacol Ther 2012; 36: 800-810ª  2012 Blackwell Publishing Ltd

    A. D. P. Mak   et al.

  • 8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics

    6/11

    factors independently associated with dyspepsia, Chi-

    squared tests were used in the whole sample to explore

    the association of the psychiatric diagnoses and sociode-

    mographic variables with dyspepsia. All diagnostic and

    sociodemographic variables were then entered into logis-

    tic regression (enter mode, without any elimination) with

    dyspepsia. Multivariate analysis did not proceed in the

    dyspepsia sub-group due to insuf cient sample size.

    Logistic regression and ordinal regression were used to

    examine factors independently associated with high

    investigation expenditure [arbitrarily dened as spending 

    HKD50000 (equivalent to USD6427) or more on investi-

    gations over the previous 5 years], frequent medical con-

    sultations (arbitrarily dened as monthly or more

    frequent medical consultations) and their respective asso-

    ciation with all diagnostic and sociodemographic vari-

    ables. Statistical analyses were performed using the

    Statistical Package for Social Studies, Version 16.0 (SPSS

    Inc., Chicago, IL, USA). All   P   values were two-tailedwith the level of statistical signicance specied at 0.05.

    RESULTS

    Prevalence and sociodemographic prole

    Of the 2011 respondents, 8.0% (n   =   161) currently ful-

    lled Rome III criteria for dyspepsia. Among these

    respondents, 81.3% (n   =  131) had postprandial distress

    syndrome (PDS), 7.5% (n   =  12) had epigastric pain syn-

    drome (EPS), 4.3% (n   =  7) had both PDS and EPS,

    while 14.9% (n   =  24) was unclassied (Table 5). Allthese subjects reported dyspeptic symptoms that were

    occurring more than once a week with onset at least

    6 months ago. Amongst all sociodemographic variables,

    only lower levels of education were signicantly associ-

    ated with dyspepsia. There was also a nonsignicant

    trend of high prevalence of dyspepsia in female.

    (Table 4).

    The 12-month prevalence of GAD was 3.8% (n   =  77).

    The 12-month prevalence of MDE, at 12.4% (n   =  249),

    has been reported before.28

    Comorbidities of dyspepsia

    Dyspepsia was signicantly associated with both GAD

    and MDE; 21.3% of respondents with MDE met Rome

    III criteria for dyspepsia vs. 6.1% of non-MDE respon-

    dents (P   <  0.001). 32.9% of dyspeptic respondents vs.

    10.6% of nondyspeptic respondents met criteria for

    MDE (P   <  0.001) (Table 6).

    In all 24.3% of GAD respondents had dyspepsia vs.

    7.3% of non-GAD respondents (P   <  0.001); 11.8% of 

    dyspepsia respondents also had GAD, vs. 3.1% of non-

    dyspepsia respondents (P   <  0.001) (Table 6).

    In the multivariate analysis that included all sociodemo-

    graphic correlates, the adjusted odds ratio of GAD being associated with dyspepsia was 2.03 (95% CI: 1.06 – 3.89,

    P   =  0.03), while the adjusted OR of MDE being associated

    with dyspepsia was 3.56 (95% CI: 2.33 – 5.43, P   <  0.001).

    Comorbidities of PDS and EPS

    Generalised anxiety disorder was found in 10.6%

    (n   =  14) of PDS [vs. 3.4% (n   =   63) non-PDS,  P   <  0.001]

    respondents and 16.7% (n   =  2) of EPS [vs. 3.8%

    (n   =  75) non-EPS] respondents. MDE was found in

    34.4% (n   =  45) of PDS respondents [vs. 10.9% (n   =  204)

    non-EPS] and 25% (n   =  3) of EPS [vs. 12.3% (n   =  246)non-EPS] respondents.

    Concomitant MDE and GAD

    Having concomitant MDE and GAD was associated with

    higher prevalence of comorbid dyspepsia than having 

    only one or none psychiatric diagnosis; 28.3% (n   =  15)

    of respondents with both GAD and MDE had dyspepsia

    (P   <  0.001), vs. 19.2% (n   =   42) with a single psychiatric

    diagnosis (P   <  0.001), and 6.0% (n   =  104) in those with-

    out psychiatric comorbidity. On multivariate analysis,

    having both GAD and MDE was signicantly associatedwith higher prevalence of dyspepsia (Adjusted

    OR   =   6.65, 95% CI: 3.35 – 13.21,   P   <   0.001) than having 

    one psychiatric diagnosis (Adjusted OR   =  3.62, 95% CI:

    2.37 – 5.51,  P   <  0.001) and no psychiatric comorbidity.

    Chronological relationship in the onset time of

    dyspepsia, GAD and MDE

    In all, 28.6% of respondents with dyspepsia reported  rst

    onset of dyspeptic symptoms before age of 20. Current

    Table 5 |   Prevalence of dyspepsia and its subgroups,

    GAD and MDE

    Prevalence,

    % (n)

    Dyspepsia (Rome III) 8.0 (161)

    Postprandial distress syndrome 81.3 (131)

    Epigastric pain syndrome 7.5 (12)Psychiatric diagnoses

    Generalised anxiety disorder 3.8 (77)

    Major depressive episode 12.4 (249)

    Number of psychiatric diagnoses

    No psychiatric diagnosis 86.5 (1739)

    One psychiatric diagnosis (GAD OR MDE) 10.9 (219)

    Two psychiatric diagnoses (GAD and MDE) 2.6 (53)

    Aliment Pharmacol Ther 2012; 36: 800-810   805ª  2012 Blackwell Publishing Ltd

    Community study on dyspepsia, depression and anxiety

  • 8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics

    7/11

    comorbidity with GAD was not signicantly associatedwith early onset of dyspeptic symptoms (33.3% dyspeptic

    respondents with comorbid GAD vs. 31.3% without co-

    morbid GAD,   P   =  1.0), nor was MDE comorbidity 

    (31.4% MDE-comorbid vs. 31.9% non-MDE-comorbid

    dyspeptic respondents,  P   =  1.0).

    For respondents with dyspepsia and MDE, 44.5%

    reported concomitant onset of the two disorders, 31.5%

    reported earlier onset of depression than dyspepsia, while

    24% reported onset of dyspepsia before depression. For

    GAD-dyspepsia comorbid respondents, up to half (54%)of the respondents reported concomitant onset of the

    disorders, while 26.7% reported having dyspepsia   rst,

    19.3% having GAD   rst. The vast majority (89.4%) of 

    those with both GAD and MDE reported concomitant

    onset of GAD and MDE, while 7.8% and 2.8% of those

    had GAD and MDE   rst respectively.

    To further examine the effect of order of onset of dys-

    pepsia and mental disorders on occurrence of dyspepsia,

    prevalence of dyspepsia was compared between subjects

    Table 6 |   Sociodemographic characteristics and psychiatric comorbidity in dyspeptic respondents

    Dyspepsia

    (n   =  161), % (n) Crude OR   P    Adjusted OR   P 

    Gender

    Male 6.9 (75) 1 1

    Female 8.9 (86) 1.32 (0.95 – 1.83) 0.10 1.16 (0.78 – 1.80) 0.47

    Age 0.6215 – 24 7.9 (27) 0.90 (0.51 – 1.56) 0.70 1.04 (0.36 – 3.02) 0.95

    25 – 34 7.1 (29) 0.79 (0.46 – 1.37) 0.40 0.90 (0.43 – 1.88) 0.77

    35 – 44 6.8 (31) 0.78 (0.46 – 1.34) 0.37 0.78 (0.40 – 1.53) 0.47

    45 – 54 9.6 (47) 1.12 (0.68 – 1.84) 0.65 1.18 (0.64 – 2.18) 0.60

    55 – 65 8.5 (27) 1   –    1   – 

    Education 0.27

    Primary or below 10.2 (23) 1.87 (1.09 – 3.19) 0.02* 1.51 (0.72 – 3.12) 0.27

    Secondary 9.1 (82) 1.61 (1.09 – 2.40) 0.02* 1.58 (0.99 – 2.53) 0.06

    Pre college 7.2 (15) 1.24 (0.67 – 2.31) 0.50 1.08 (0.54 – 2.15) 0.83

    College or above 5.8 (39) 1   –    1   – 

    Work status 0.89

    Employed 7.6 (92) 0.74 (0.47 – 1.15) 0.18 0.88 (0.51 – 1.53) 0.27

    Unemployed 8.5 (11) 0.85 (0.41 – 1.76) 0.66 0.87 (0.39 – 1.95) 0.74

    Retired 5.7 (8) 0.55 (0.25 – 

    1.24) 0.15 0.60 (0.23 – 

    1.60) 0.31Student 7.9 (19) 0.77 (0.42 – 1.41) 0.39 0.82 (0.28 – 2.39) 0.72

    Homemaker 10.1 (28) 1   –    1   – 

    Marital status 0.94

    Single 7.5 (58) 1   –    1   – 

    Married/living together 8 (95) 1.08 (0.77 – 1.52) 0.66 0.95 (0.57 – 1.60) 0.85

    Previously married 14 (6) 1.93 (0.77 – 4.83) 0.16 1.11 (0.39 – 3.15) 0.85

    Income level 0.88

    HKD     10 000 9.5 (30.4) 1.44 (0.75 – 2.76) 0.28 0.89 (0.41 – 1.87) 0.73

    HKD 10 000 – 30 000 7.9 (69) 1.17 (0.83 – 2.15) 0.62 0.84 (0.43 – 1.65) 0.62

    HKD 30 000 – 60 000 6.5 (27) 0.95 (0.48 – 1.88) 0.88 0.75 (0.37 – 1.54) 0.44

    HKD 60 000 6.8 (13) 1   –    1   – 

    Psychiatric diagnoses

    GAD

    No GAD

    24.3 (19)

    7.3 (142)

    4.10 (2.37 – 7.08)  

  • 8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics

    8/11

    with onset of mental disorders (GAD or MDE) preced-

    ing dyspepsia (To allow comparison, this group also

    comprised those with only mental disorders now, based

    on the assumption of future onset of dyspepsia) and

    those where onset of mental disorders did not precede

    dyspepsia. Dyspepsia was not more common in those

    with mental disorders preceding dyspepsia (7.7%) com-

    pared with those where mental disorders did not precede

    dyspepsia (8.0%,  P   =  0.87). On multivariate analysis that

    included all other sociodemographic factors, the associa-

    tion of precedent-onset mental disorders with dyspepsia

    remained insignicant (Adjusted OR   =  0.83 95% CI:

    0.47 – 1.45,  P   =  0.51).

    Frequent medical consultations

    Frequent medical consultations were, on univariate analy-

    sis, less common amongst male (M 10.9% vs. F 17.3%,

    P   <   0.001) and students. It was more common amongst

    homemakers (Employed 14.9%, unemployed 14.1%,retired 17.1%, students 5%, homemakers 18.8%; P   =  0.04).

    Respondents with dyspepsia made signicantly more

    frequent medical consultations than those with no dys-

    pepsia (31.7% vs. 12.8%,   P   <  0.001). GAD and MDE

    were also associated with more frequent medical consul-

    tations (36.8% GAD vs. 13.5% non-GAD,   P   <  0.001;

    30.4% MDE vs. 12.1% non-MDE,   P   <   0.001). Using 

    multivariate analysis, dyspepsia (Adjusted OR   =  2.48,

    95% CI: 1.65 – 3.72   P   <  0.001), MDE (Adjusted

    OR   =  2.39, 95% CI: 1.64 – 3.46,  P   <  0.001), female gender

    (Adjusted OR   =  1.65, 95% CI: 1.21 – 

    2.23,   P   <  0.001)were all found to be independent predictors of frequent

    medical consultations.

    High investigation expenditure

    In all, 14% of dyspeptic respondents vs. 9.4% of nondys-

    peptic respondents spent moderately [dened as more

    than HKD10000 (equivalent to USD 1289) on medical

    investigations over the past 5 years]. 3.2% dyspeptic vs.

    1.3% nondyspeptic respondents had high investigation

    expenditure [dened as spending more than hkd 50 000

    (equivalent to USD 6449) on medical investigations overthe past 5 years]. There was a statistically nonsignicant

    trend of dyspepsia being associated with high investiga-

    tion expenditure (P   =  0.06). GAD (5.6% vs. 1.3%,

    P   =  0.003), but not MDE (2.5% vs. 1.3%,   P   =  0.16),

    was associated with high investigation expenditure on

    univariate analysis. GAD was the only signicant

    predictor of high investigation expenditure on multivari-

    ate analysis (Adjusted OR   =   4.65, 95% CI: 1.15 – 18.70,

    P   =  0.03).

    DISCUSSION

    We set out to determine the current prevalence of 

    dyspepsia with stringent Rome III symptom criteria in a

    random, representative Chinese community sample.

    Participation rate was comparable to previous telephone

    health surveys.26 We observed that dyspepsia was

    strongly associated and often had coincident onset with

    GAD and MDE in the community.

    Direct comparisons for community prevalence of 

    Rome III dyspepsia are sparse. Our conservative   gure

    was, possible cross-national variation aside, consistent

    with the Rome III restrictiveness.3 Omission of the

    6-month onset requirement from Rome III criteria may 

    explain the high prevalence of 20% in the Kalixanda

    study.15 We found dyspepsia slightly more common in

    females, as in local and overseas data.14, 15 Our GAD

    prevalence and sociodemographic correlates were consis-

    tent with extant community data, which were also

    similar to Western   ndings and a previous identically designed survey in Hong Kong.26 The 12.4% MDE

    prevalence, reported previously, was higher than the

    2007   gure of 8.5%, probably related to the 2008 global

    nancial crisis.28

    We found signicant and independent association of 

    dyspepsia with GAD and MDE as mental disorders. This

    is consistent with the reported association of anxiety 

    symptoms with dyspepsia.4, 15 The link with depression

    is more controversial. While we found a strong associa-

    tion between MDE and dyspepsia, even higher than that

    for GAD, the Kalixanda study found anxiety but notdepression to be associated with dyspepsia.15 This may 

    be due to the inclusion of dyspepsia of shorter duration

    in the Kalixanda study, which may have a weaker associ-

    ation with depression than anxiety. In addition, the

    HADS depression subscale comprises only symptom

    scores over 1 week ’s duration and had no requirement

    for functional impairment, and therefore it was substan-

    tially less accurate than DSM-IV-TR MDE, which

    required 2 weeks of depressive symptoms causing signi-

    cant functional impairment or marked distress (Table 3).

    Nonetheless, signicant association between dyspepsiaand depressive symptoms was noted in a previous local

    community survey using HADS and Rome II,14 as well

    as a meta-analysis.4 Future surveys on psychiatric com-

    orbidity using standard diagnostic assessment will help

    clarify the relationship between dyspepsia and depres-

    sion.

    GAD and MDE were both more common in PDS,

    while only GAD was signicantly more common in EPS.

    In view of the small sample size, between-group

    Aliment Pharmacol Ther 2012; 36: 800-810   807ª  2012 Blackwell Publishing Ltd

    Community study on dyspepsia, depression and anxiety

  • 8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics

    9/11

    comparison would not be meaningful and as such should

    be examined in larger community samples.

    Particularly salient was the  nding that GAD and MDE,

    as mental disorders each having distinct biological and

    environmental aetiologies, were associated with dyspepsia.

    While cross-sectional studies map chronology poorly, our

    preliminary  ndings were that most of the comorbid sub-

     jects had coincident onset of mental disorders and dyspep-

    sia, and that preceding mental disorders were not a

    signicant risk factor for dyspepsia. Coincident-onset thus

    appears to be the predominant mode of comorbidity. This

    disputes the assertion of distress from dyspepsia itself 

    totally explaining its association with depressive and anxi-

    ety features. It is also against the view of mental disorders

    ‘causing ’  dyspepsia. Rather, the   nding is consistent with

    neurophysiological   ndings that autonomic nervous sys-

    tem and hypothalamo-pituitary-adrenal axis derange-

    ments typical of anxiety disorders and depressive

    disorders29 may alter gastrointestinal function.30 It alsoconcurs with evidence that onset of dyspeptic symptoms

    ‘behaves’   similarly as anxiety and depressive disorders as

    systemic reactions to major stressful life events.31 This

    strong association between dyspepsia, GAD and MDE

    implies that mental disorders should be routinely screened

    during the assessment of patients with dyspepsia.

    The stepwise increase in risk of dyspepsia with

    increased number of psychiatric diagnoses mirrors

    evidence from the psychosomatic literature that supports

    a dose-response link between somatic symptom load and

    psychopathology.32 Studies with larger samples anddetailed severity measures should conrm whether

    dyspeptic symptoms could predict level of psychiatric

    morbidity in a proportionate manner. Methodologically,

    this stresses the value of including both anxiety and

    depressive disorders when studying psychiatric comor-

    bidity of medical disorders.

    Psychiatric comorbidity seemed to have a complex 

    impact on healthcare use. In this study, dyspepsia and

    MDE independently predicted frequent medical consulta-

    tions while GAD predicted high investigation expendi-

    ture. The extent of somatic symptoms is unlikely toexplain the difference, as patients with both GAD and

    MDE are associated with frequent physical complaints

    that would drive healthcare use.32 Variances in doctor-

    patient interaction and cognitive factors may be other

    explanations. In particular, more than 70% of GAD

    sufferers have excessive health anxiety,33 which may 

    drive medical decisions into ordering more investiga-

    tions. For MDE, medical consultations may be driven by 

    the distinct distress and impairment in depression, and

    increased mental health literacy of patients regarding 

    depression as an illness.

    Our study has several limitations. First, endoscopy was

    not done. It is uncertain how strictly applied Rome III

    dyspepsia symptom criteria would predict lack of orga-

    nicity. However, the subgroup of subjects with peptic

    ulcer disease and gastric ulcer is likely to be a small

    minority. Our previous endoscopy study in referred

    patients with dyspepsia found organicity in less than 10%

    of patients.34 The Kalixanda study found no organicity in

    77% of uninvestigated dyspepsia cases,15 while a meta-

    analysis found positive endoscopy in 20% of dyspeptics,

    only 6% in Rome-dened dyspeptics.35 Second, we did a

    brief telephone survey instead of a detailed face-to-face

    one. However, by avoiding face-to-face contact, telephone

    surveys may avoid psychiatric stigma, and facilitate dis-

    closure of sensitive information.36 This is critical for the

    Chinese for whom disclosing psychological distress may 

    be culturally inhibited.37 Third, other potentially impor-tant factors associated with dyspepsia were omitted owing 

    to the need for brevity in a telephone survey, such as

    medication use. Fourth, recall bias and cross-sectional

    design limited the study of chronology. In particular, our

    analysis on order of onset and prevalence of dyspepsia

    had a clear limitation in assuming future onset of 

    dyspepsia for those with only mental disorders cur-

    rently, but such   ‘comorbidity ’   was not inevitable. The

    order of onset thus designated was limited by this

    assumption and any implications on causality need to

    be studied more rigorously in future prospective com-munity studies. Fifth, the study was underpowered for

    multivariate analysis for variables associated with psy-

    chiatric comorbidity and healthcare utilisation in the

    dyspepsia subgroup. Future population-based studies

    using larger samples may endeavour to explore this

    area. Lastly, we assessed current prevalence of dyspepsia

    and 12-month prevalence of GAD and MDE so as to

    render the   ndings comparable to other community 

    surveys. It should be noted that this approach may 

    somewhat inate the prevalence   gures for the mental

    disorders relative to that of dyspepsia.In conclusion, we found Rome III dyspepsia to be

    common and strongly associated with MDE and GAD as

    mental disorders, with substantial impact on healthcare

    use in the community. The implications are that one,

    mental disorders should be routinely screened in assess-

    ing dyspepsia, especially those exhibiting high levels of 

    healthcare use. Two, clinicians treating dyspepsia with

    comorbid GAD or MDE should regard help-seeking 

    behaviour as a salient part of illness experience. Instead

    808   Aliment Pharmacol Ther 2012; 36: 800-810ª  2012 Blackwell Publishing Ltd

    A. D. P. Mak   et al.

  • 8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics

    10/11

    of routinely discouraging unnecessary consultations or

    investigations, holistic and effective approaches in treat-

    ing these complexly ill individuals may do their health

    better while reducing unnecessary expenses. Collabora-

    tive psychosomatic care involving gastroenterologists and

    mental health professionals may address this. Lastly, pro-

    spective research is needed on courses of dyspepsia and

    comorbid mental disorders, as well as translational

    research in such light.

    ACKNOWLEDGEMENTS

    Declaration of personal interests: Dr Arthur Mak is sup-

    ported by an educational grant of Pzer Pharmaceutical.

    Dr Justin Wu is supported by research funds of Depart-

    ment of Medicine & Therapeutics and educational grant

    of Pzer Pharmaceutical. Dr Sing Lee received educa-

    tional grants on mental health education from Pzer

    Pharmaceuticals, GlaxoSmithkline, Wyeth Pharmaceuti-

    cals and Johnson & Johnson Pharmaceuticals.   Declara-

    tion of funding interests: None.

    SUPPORTING INFORMATION

    Additional Supporting Information may be found in theonline version of this article:

    Appendix S1.   Comparison of study sample composi-

    tion and 2008 Hong Kong Census population data, and

    weighting factor applied.

    Please note: Wiley-Blackwell are not responsible for

    the content or functionality of any supporting materials

    supplied by the authors. Any queries (other than missing 

    material) should be directed to the corresponding author

    for the article.

    REFERENCES

    1. Agreus L, Borgquist L. The cost of gastro-oesophageal reux disease,dyspepsia and peptic ulcer disease inSweden. Pharmacoeconomics  2002;  20:347 – 55.

    2. El-Serag HB, Talley NJ. Systemicreview: the prevalence and clinicalcourse of functional dyspepsia.

     Aliment Pharmacol Ther   2004;   19:643 – 54.

    3. Tack J, Talley NJ, Camilleri M,  et al.

    Functional gastroduodenal disorders.Gastroenterology  2006;   130: 1466 – 79.

    4. Henningsen P, Zimmermann T, SattelH. Medically unexplained physicalsymptoms, anxiety, and depression: ameta-analytic review.  Psychosom Med 2003; 65 : 528 – 33.

    5. Hasin DS, Goodwin RD, Stinson FS,Grant BF. Epidemiology of majordepressive disorder: results from theNational Epidemiologic Survey onAlcoholism and Related Conditions.

     Arch Gen Psychiatry  2005;  62 : 1097 – 106.

    6. Carter RM, Wittchen HU, Pster H,

    Kessler RC. One-year prevalence of subthreshold and threshold DSM-IVgeneralized anxiety disorder in anationally representative sample.Depress Anxiety  2001;  13:  78 – 88.

    7. Van Oudenhove L, Vandenberghe J,Geeraerts B,  et al.  Relationship betweenanxiety and gastric sensorimotorfunction in functional dyspepsia.Psychosom Med  2007;  69 : 455 – 63.

    8. Lehoux CP, Abbott FV. Pain, sensory function, and neurogenic inammatory response in young women with low 

    mood.   J Psychosom Res  2011;   70:241 – 9.

    9. de Medeiros MT, Carvalho AF, DeOliveira Lima JW, Dos Santos AA, deOliveira RB, Nobre ESMA. Impact of depressive symptoms on visceralsensitivity among patients with differentsubtypes of irritable bowel syndrome.  J Nerv Ment Dis  2008;  196 : 711 – 4.

    10. Blomhoff S, Spetalen S, Jacobsen MB,Malt UF. Phobic anxiety changes the

    function of brain-gut axis in irritablebowel syndrome.  Psychosom Med  2001;63: 959 – 65.

    11. Haug TT, Svebak S, Wilhelmsen I,Berstad A, Ursin H. Psychologicalfactors and somatic symptoms infunctional dyspepsia. A comparisonwith duodenal ulcer and healthy controls. J Psychosom Res 1994; 38:281 – 91.

    12. Koloski NA, Talley NJ, Boyce PM.Does psychological distress modulatefunctional gastrointestinal symptomsand health care seeking? A prospective,community Cohort study.  Am J 

    Gastroenterol  2003;  98 : 789 – 

    97.13. Pajala M, Heikkinen M, Hintikka J. A

    prospective 1-year follow-up study inpatients with functional or organicdyspepsia: changes in gastrointestinalsymptoms, mental distress and fear of serious illness.  Aliment Pharmacol Ther 2006;  24 : 1241 – 6.

    14. Hu WH, Wong WM, Lam CL,  et al.Anxiety but not depression determineshealth care-seeking behaviour inChinese patients with dyspepsia andirritable bowel syndrome: a population-

    based study.  Aliment Pharmacol Ther 2002; 16 : 2081 – 8.

    15. Aro P, Talley NJ, Ronkainen J,  et al.Anxiety is associated withuninvestigated and functional dyspepsia(Rome III criteria) in a Swedishpopulation-based study.Gastroenterology  2009;  137 : 94 – 100.

    16. American Psychiatric Association.Diagnostic and Statistical Manual for 

     Mental Disorders, 4th edn. Text

    Revision. Washington, DC: AmericanPsychiatric Association, 2000.

    17. So EK, Kam I, Leung CM, Chung D,Liu Z, Fong S. The Chinese-bilingualSCID-I/P Project: stage 1 - reliability for mood disorders and schizophrenia.Hong Kong J Psychiatry  2003;  13 :7 – 18.

    18. Tse AW, Lai LH, Lee CC,  et al.Validation of self-administratedquestionnaire for psychiatric disordersin patients with functional dyspepsia.  J Neurogastroenterol Motil  2010;  16 : 52 – 60.

    19. Eaton WW, Kramer M, Anthony JC,

    Drman A, Shapiro S, Locke BZ.Conceptual and methodologicalproblems in estimation of the incidenceof mental disorders from   eld survey data. In: Copper BH, Helgason T, eds.Epidemiology and the Prevention of Survey Data. London: Routledge, 1989;108 – 27.

    20. Census & Statistics Department tGotH.Hong Kong Statistics. Hong Kong 2009 .Available at: http://www.statistics.gov.hk/pub/B10100032009AN09B0700.pdf.Accessed December 1, 2011.

    Aliment Pharmacol Ther 2012; 36: 800-810   809ª  2012 Blackwell Publishing Ltd

    Community study on dyspepsia, depression and anxiety

  • 8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics

    11/11

    21. Functional Dyspepsia Module.  Tampa,Florida: Rome Foundation, Inc .Available at: http://www.romecriteria.org/pdfs/DyspepMode.pdf. AccessedDecember 1, 2011.

    22. Lee S, Tsang A, Chui H, Kwok K, Cheung E. A community epidemiological survey of generalized anxiety disorder in Hong Kong. Community Ment Health J  2007;

    43: 305 – 

    19.23. Lee S, Tsang A, Kwok K. Twelve-

    month prevalence, correlates, andtreatment preference of adults withDSM-IV major depressive episode inHong Kong.  J Affect Disord  2007;  98 :129 – 36.

    24. Lee S, Tsang A, Lau L, Mak A, Ng KL,Chan DM. Concordance betweentelephone survey classication and face-to-face structured clinical interview inthe diagnosis of generalized anxiety disorder in Hong Kong.  J Anxiety Disord  2008;  22 : 1403 – 11.

    25. Lee S, Tsang A, Mak A, Lee A, Lau L,

    Ng KL. Concordance betweentelephone survey classication andface-to-face interview diagnosis of one-year major depressive episode inHong Kong.  J Affect Disord  2010;  126 :155 – 60.

    26. Lee S, Wu J, Ma YL, Tsang A, Guo WJ,Sung J. Irritable bowel syndrome is

    strongly associated with generalizedanxiety disorder: a community study.

     Aliment Pharmacol Ther  2009;  30 :643 – 51.

    27. Hsieh FY, Block DA, Larsen MD. Asimple method of sample sizecalculation for linear and logisticregression. Stat Med  1998;  17 : 1623 – 34.

    28. Lee S, Guo WJ, Tsang A,  et al.

    Evidence for the 2008 economic crisisexacerbating depression in Hong Kong.

     J Affect Disord  2010;  2 : 125 – 33.29. Holsboer FK, Kunzel HE. Clinical

    neuroendocrinology. In: Charney DS,Nestler EJ, eds.  Neurobiology of Mental Illness. New York: Oxford University Press, 2004; 155 – 70.

    30. Tache Y, Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motorfunction. J Clin Invest  2007;  117 : 33 – 40.

    31. Naliboff BD, Mayer M, Fass R,  et al.The effect of life stress on symptoms of heartburn. Psychosom Med  2004;  66 :

    426 – 

    34.32. Kroenke K, Jackson JL, Chamberlin J.

    Depressive and anxiety disorders inpatients presenting with physicalcomplaints: clinical predictors andoutcome. Am J Med  1997;  103 : 339 – 47.

    33. Lee S, Ma YL, Tsang A. A community study of generalized anxiety disorder

    with vs. without health anxiety in Hong Kong. J Anxiety Disord  2011; 25: 376 – 80.

    34. Sung JJ, Lao WC, Lai MS,  et al.Incidence of gastroesophagealmalignancy in patients with dyspepsiain Hong Kong: implications forscreening strategies.  Gastrointest Endosc 2001;  54 : 454 – 8.

    35. Ford AC, Marwaha A, Lim A,

    Moayyedi P. What is the prevalence of clinically signicant endoscopic  ndingsin subjects with dyspepsia? Systematicreview and meta-analysis.  ClinGastroenterol Hepatol  2010;  8 : 830 – 7.

    36. McQueen DV. Comparison of results of personal interview and telephonesurveys of behavior related to risk of AIDS: advantages of telephonetechniques. In: Fowler F, ed.  HealthSurvey Research Methods: ConferenceProceedings. Washington, DC:Government Printing Of ce, 1989;247 – 52.

    37. Ho DYF, Fu W, Ng SM. Guilt, shame

    and embarrassment: revelations of face and self.   Culture Psychology   2004;10: 64 – 84.

    810   Aliment Pharmacol Ther 2012; 36: 800-810ª  2012 Blackwell Publishing Ltd

    A. D. P. Mak   et al.